Position Map Data

Total Page:16

File Type:pdf, Size:1020Kb

Position Map Data Cat. ID for plate order: SRP0111 Plate product name: Transcription Factor siRNA library set, plate 1 1 2 3 4 5 6 7 8 9 10 11 12 PPARGC1B AR (m) DNMT3L (m) HDAC10 (m) MED4 (m) THRAP3 (m) UBA52 (m) ALX3 (m) C2orf3 (m) DEAF1 (m) A (m) B BCOR (m) DYRK1B (m) HEXIM1 (m) MITF (m) RBM9 THRAP4 (m) YAF2 (m) ARNTL (m) CBFA2T3 (m) DLX1 (m) C CREB3 (m) E2F4 (m) IFI16 (m) MKL2 (m) RING1 (m) THRAP5 (m) ZBTB17 (m) ARX (m) CDX1 (m) DLX5 (m) D CREB5 EGR2 (m) ILF3 (m) NKRF SUB1 (m) THRAP6 (m) ZHX1 (m) ATM (m) CHURC1 (m) DPRX E CRSP2 (m) ELF2 (m) LMX1B (m) NPM1 (m) TAF1L TP53 (m) ZHX2 (m) BARHL1 CHX10 (m) E2F6 (m) F CRSP6 (m) ELL3 (m) MDM2 (m) PHB (m) TBX5 (m) TP73L (m) ZHX3 (m) BARHL2 (m) CITED4 (m) E2F7 (m) G CXXC1 (m) GATAD2A (m) CRTC1 (m) PIAS4 (m) TGFB1I1 (m) TRERF1 (m) ZNF24 (m) BARX2 (m) CREB3L1 (m) E2F8 (m) H DDX54 (m) HBXAP MED12 (m) PPARBP (m) THRAP1 (m) TRRAP ADNP (m) BHLHB8 (m) CREM ELF1 (m) The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes. Cat. ID for plate order: SRP0112 Plate product name: Transcription Factor siRNA library set, plate 2 1 2 3 4 5 6 7 8 9 10 11 12 A ELF5 (m) ESRRG (m) FOXD4L1 FOXN4 (m) GATA5 (m) HOXA10 (m) HOXC12 (m) IRF5 (m) LBX1 (m) MAX (m) RP11- ELK1 (m) ESX1L (m) FOXO3A (m) GATAD2B (m) HOXA11 (m) HOXC6 (m) IRF6 (m) LEF1 (m) MED31 (m) B 561O23.3 C EMX2 (m) ETV2 FOXD4L3 FOXP1 (m) GMEB1 (m) HOXA13 (m) HOXC9 (m) IRX3 (m) LHX2 (m) MEOX1 (m) D EN1 (m) ETV3 FOXD4L4 FOXP2 (m) GSC (m) HOXA2 (m) HOXD1 (m) IRX4 (m) LHX4 (m) MIXL1 (m) E EN2 (m) ETV4 (m) FOXG1B (m) FOXP4 (m) HESX1 (m) HOXA3 (m) HOXD13 (m) IRX5 (m) LHX5 (m) MIZF (m) F ERG (m) FLJ25680 FOXH1 (m) FOXQ1 (m) HIF3A (m) HOXA6 (m) ID1 (m) ISL1 (m) LHX8 (m) MLLT7 (m) G ESRRA (m) FOXB1 (m) FOXJ2 (m) FOXR1 (m) HLX1 (m) HOXA9 (m) ID2 (m) ISL2 (m) LHX9 (m) MSX2 (m) H ESRRB (m) FOXC2 (m) FOXJ3 (m) FOXR2 (m) HOP (m) HOXB13 (m) IRF1 (m) L3MBTL (m) LMX1A MTA1 (m) The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes. Cat. ID for plate order: SRP0113 Plate product name: Transcription Factor siRNA library set, plate 3 1 2 3 4 5 6 7 8 9 10 11 12 A MTA2 (m) NFATC4 (m) NR1H2 (m) NR4A2 (m) PBX3 (m) RARB (m) SALF SPDEF (m) TBPL1 (m) TGIF2LX (m) B MTA3 (m) NHLH2 (m) NR1H3 (m) NR4A3 (m) PEPP-2 RARG (m) SATB1 (m) SPIC (m) TBX2 (m) TGIF2LY C MXD3 (m) NKX2-2 (m) NR1I2 (m) NR5A1 (m) PITX1 (m) RFX2 (m) SIX1 (m) ST18 (m) TBX6 (m) TITF1 (m) D MYST2 (m) NKX2-3 (m) NR2C1 (m) NR6A1 (m) PITX2 (m) RORA (m) SIX3 (m) STAT2 (m) TCF2 (m) TLX1 (m) E MYT1L (m) NPAS3 (m) NR2E1 (m) NRF1 (m) PITX3 (m) RORB (m) SIX4 (m) SUPT4H1 (m) TEAD1 (m) TLX3 (m) F NANOG NR0B2 (m) NR2E3 (m) ONECUT1 (m) PKNOX2 RORC (m) SIX5 (m) TAF6L (m) TFAP2A (m) TOE1 (m) NEUROG3 NR1D1 (m) NR2F6 (m) PAX4 (m) POU2F3 (m) RXRA (m) SIX6 (m) TAF7L (m) TFAP2D (m) TSC22D1 (m) G (m) H NFATC3 (m) NR1D2 (m) NR4A1 (m) PBX2 (m) PRRX1 (m) RXRG (m) SP110 (m) TAL1 (m) TFAP2E (m) TSC22D2 (m) The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes. Cat. ID for plate order: SRP0114 Plate product name: Transcription Factor siRNA library set, plate 4 1 2 3 4 5 6 7 8 9 10 11 12 A TSC22D4 (m) ZNF213 (m) ZNF397 ZNF96 (m) ARNT2 (m) GLIS3 (m) SMAD5 (m) ASCL2 (m) BTAF1 (m) CTNNB1 (m) B VDR (m) ZNF232 ZNF435 ZNRD1 (m) CARM1 (m) HDAC6 (m) TWIST2 ATF7 (m) CBX2 DDIT3 (m) C VGLL2 (m) ZNF287 (m) ZNF444 (m) ZSCAN1 CBFA2T2 (m) KLF4 (m) ZBTB7A (m) BARX1 (m) CD80 (m) DMAP1 (m) D ZFHX1B (m) ZNF306 (m) ZNF446 (m) ZSCAN2 (m) DMBX1 (m) NKX2-5 (m) AHR (m) BAZ1B (m) CDK7 (m) DMTF1 (m) E ZFHX4 (m) ZNF323 ZNF449 (m) ZSCAN4 (m) EHF (m) PHF5A (m) ANKRD30A BAZ2A (m) CEBPA (m) DNM2 (m) F ZFY (m) ZNF38 (m) ZNF452 ZSCAN5 FOXD3 (m) PPARD (m) ARID3A (m) BCL6 (m) CEBPB (m) E2F5 (m) G ZNF193 ZNF394 (m) ZNF690 (m) C10orf48 (m) GATA4 (m) SCAND1 (m) ARNTL2 (m) BHLHB2 (m) CNOT8 (m) EED (m) H ZNF206 (m) ZNF396 ZNF694 ARID1A (m) GLIS1 (m) SMAD1 (m) ASCL1 (m) BHLHB3 (m) CRX (m) EGR4 (m) The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes. Cat. ID for plate order: SRP0115 Plate product name: Transcription Factor siRNA library set, plate 5 1 2 3 4 5 6 7 8 9 10 11 12 A ELF4 (m) FOXJ1 (m) HMG20A (m) HOXB4 (m) HOXD12 (m) KLP1 (m) MLLT10 (m) NFIA (m) OTX2 (m) RBM14 (m) B ELK4 (m) FOXL2 (m) HMG20B HOXB6 (m) HOXD4 (m) LRRFIP1 MLX (m) NKX3-1 (m) PBX1 (m) REL (m) C ESR1 (m) FOXP3 (m) HMX1 HOXB7 (m) HOXD8 (m) MAFG MYB (m) NKX6-2 PBXIP1 (m) RFX5 (m) D ETS2 (m) GTF2H2 (m) HMX2 HOXB8 (m) HR (m) MAFK (m) MYT1 (m) NR0B1 (m) PHOX2A (m) RFXANK (m) E FHL2 (m) GTF2H3 (m) HNRPD HOXB9 (m) HTATIP (m) MBD2 (m) NAB1 (m) NRIP1 (m) PIAS2 (m) RFXAP (m) F FOXA2 (m) GTF2IRD1 (m) HOXA5 (m) HOXC4 (m) IKBKB (m) MEF2A (m) NCOA1 (m) NSBP1 (m) PRIC285 (m) RNF12 (m) G FOXF1 (m) HCFC1 (m) HOXB1 (m) HOXC8 (m) KLF2 (m) MEF2B (m) NCOA2 (m) OTEX PRRX2 (m) RXRB (m) H FOXF2 (m) HEYL (m) HOXB2 (m) HOXD11 (m) KLF3 (m) MEF2D (m) NCOA3 (m) OTX1 (m) RARA (m) SCRT1 (m) The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes. Cat. ID for plate order: SRP0116 Plate product name: Transcription Factor siRNA library set, plate 6 1 2 3 4 5 6 7 8 9 10 11 12 A SIX2 (m) TAF1B (m) TFEB (m) WWTR1 (m) ZNF42 (m) MAZ (m) HMGA1 (m) AEBP1 (m) ARID5A (m) ATF3 (m) B SOX1 (m) TCF20 (m) TGIF2 (m) ZFP37 (m) ZNF83 MEOX2 (m) MMS19L (m) AFF1 (m) ARID5B (m) ATF4 (m) C SOX2 (m) TCF3 (m) THRB (m) ZNF187 (m) ZNF91 NKX6-1 (m) MYCBP AFF4 (m) ARNT (m) ATF5 (m) D SOX6 (m) TCF7L1 (m) TP53BP1 (m) ZNF236 (m) GFI1 (m) RBPSUH (m) PCAF (m) AIP (m) ASH1L (m) ATF6 (m) E SP1 (m) TEAD2 (m) TTF1 (m) ZNF253 GTF2E2 (m) TAF15 (m) PIAS3 (m) AIRE (m) ASH2L (m) ATOH1 (m) F SP3 (m) TFAP2B (m) VAX2 (m) ZNF268 HOXB3 (m) TCF21 (m) TCEB1 (m) ALF (m) ATBF1 (m) BACH1 (m) G SRY TFDP2 (m) VSX1 (m) ZNF398 (m) HOXB5 (m) TRIM24 (m) TCEB3 (m) APEX1 (m) ATF1 (m) BAPX1 (m) H T (m) TFE3 (m) WT1 (m) ZNF41 HOXD3 (m) TWIST1 (m) ABT1 (m) ARID4A (m) ATF2 (m) BATF The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes. Cat. ID for plate order: SRP0117 Plate product name: Transcription Factor siRNA library set, plate 7 1 2 3 4 5 6 7 8 9 10 11 12 A BCLAF1 (m) C19orf2 (m) CHES1 (m) COPS5 (m) CRSP8 (m) DLX2 (m) DTX1 (m) ELF3 (m) ERF (m) FEV (m) B BLZF1 (m) CART1 (m) CIITA (m) CREB1 (m) CRSP9 (m) DLX3 (m) E2F1 (m) ELL (m) ESR2 (m) FKHL18 (m) C BNC1 (m) CBFB (m) CIR (m) CREBBP (m) CSDA (m) DLX4 (m) E2F2 (m) ELL2 (m) ETS1 (m) FLI1 (m) D BRCA1 (m) CBL (m) CITED1 (m) CREBL1 (m) CSEN (m) DMRT1 (m) E2F3 (m) EP300 (m) ETV1 (m) FOS (m) E BRD8 (m) CBX4 (m) CITED2 CREBL2 (m) CTCF (m) DMRT2 (m) E4F1 (m) EPAS1 (m) ETV5 (m) FOSL1 (m) F BRDT (m) CCRN4L (m) CLOCK (m) CREG1 (m) CUTL1 (m) DR1 (m) EDF1 (m) EPC1 (m) ETV6 (m) FOSL2 (m) G BRF1 (m) CDX2 (m) CNOT2 (m) CRSP3 (m) DBP (m) DRAP1 (m) EGR1 (m) ERCC6 (m) ETV7 FOXA1 (m) H BTF3 (m) CEP1 (m) CNOT7 (m) CRSP7 (m) DEK (m) DSCR1 EGR3 (m) ERCC8 (m) EVX1 (m) FOXA3 (m) The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes. Cat. ID for plate order: SRP0118 Plate product name: Transcription Factor siRNA library set, plate 8 1 2 3 4 5 6 7 8 9 10 11 12 A FOXC1 (m) FOXL1 (m) GAS7 (m) GLI1 (m) GTF2F1 (m) GTF3C5 (m) HES6 (m) HKR3 HOXC10 (m) HSF2 (m) B FOXD1 (m) FOXM1 (m) GATA1 (m) GLI2 (m) GTF2H4 (m) HAND1 (m) HEY1 (m) HLXB9 (m) HOXC11 (m) HSF4 (m) C FOXD2 (m) FOXN1 (m) GATA2 (m) GLI3 (m) GTF2I (m) HCLS1 (m) HEY2 (m) HMGB2 (m) HOXC13 (m) HSGT1 (m) D FOXD4 FOXO1A (m) GATA3 (m) GMEB2 (m) GTF3A HDAC1 (m) HHEX (m) HMGN1 (m) HOXC5 (m) HTATIP2 (m) E FOXE1 (m) FUBP1 (m) GATA6 (m) GRLF1 GTF3C1 (m) HDAC4 (m) HIC1 (m) HNF4A (m) HOXD10 (m) HTATSF1 (m) F FOXE3 (m) G10 GBX2 (m) GSCL (m) GTF3C2 (m) HDAC5 (m) HIF1A (m) HNF4G (m) HOXD9 (m) HTLF (m) G FOXI1 (m) GABPA (m) GCN5L2 (m) GTF2A1 (m) GTF3C3 (m) HDAC7A (m) HIPK2 HOXA1 (m) HSBP1 (m) ID3 (m) H FOXK2 (m) GABPB2 (m) GFI1B (m) GTF2B (m) GTF3C4 (m) HDAC9 (m) HIRA (m) HOXA7 (m) HSF1 (m) ID4 (m) The gene symbol follow by "(m)" denotes that this siRNA is also capable to knockdown the mouse homolog genes.
Recommended publications
  • Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
    Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10.
    [Show full text]
  • Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-Like Mouse Models: Tracking the Role of the Hairless Gene
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2006 Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene Yutao Liu University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Life Sciences Commons Recommended Citation Liu, Yutao, "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino- like Mouse Models: Tracking the Role of the Hairless Gene. " PhD diss., University of Tennessee, 2006. https://trace.tennessee.edu/utk_graddiss/1824 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Yutao Liu entitled "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Life Sciences. Brynn H. Voy, Major Professor We have read this dissertation and recommend its acceptance: Naima Moustaid-Moussa, Yisong Wang, Rogert Hettich Accepted for the Council: Carolyn R.
    [Show full text]
  • ZNF652, a Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor Suppressor CBFA2T3 to Repress Transcription
    ZNF652, A Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor Suppressor CBFA2T3 to Repress Transcription Raman Kumar,1 Jantina Manning,1 Hayley E. Spendlove,3 Gabriel Kremmidiotis,4 Ross McKirdy,1 Jaclyn Lee,1 David N. Millband,1 Kelly M. Cheney,1 Martha R. Stampfer,5 Prem P. Dwivedi,2 Howard A. Morris,2 and David F. Callen1 1Breast Cancer Genetics Group, Dame Roma Mitchell Cancer Research Laboratories, Department of Medicine, University of Adelaide and Hanson Institute; 2Endocrine Bone Laboratory, Hanson Institute, Adelaide, South Australia, Australia; 3Department of Laboratory Genetics, Women’s and Children’s Hospital, North Adelaide, South Australia, Australia; 4Bionomics, Ltd., Thebarton, South Australia, Australia; and 5Lawrence Berkeley National Laboratory, Berkeley, California Abstract gene effector zinc finger proteins may specifically The transcriptional repressor CBFA2T3is a putative interact with one or more of the ETO proteins to generate breast tumor suppressor. To define the role of CBFA2T3, a defined range of transcriptional repressor complexes. we used a segment of this protein as bait in a yeast (Mol Cancer Res 2006;4(9):655–65) two-hybrid screen and identified a novel uncharacterized protein, ZNF652. In general, primary tumors and cancer Introduction cell lines showed lower expression of ZNF652 than Tumor growth, characterized by unchecked cell division, normal tissues. Together with the location of this gene results from both the overexpression of growth-promoting on the long arm of chromosome 17q, a region of frequent oncogenes and the reduced expression of growth-inhibiting loss of heterozygosity in cancer, these results suggest tumor suppressor genes. These genes often encode proteins that In silico a possible role of ZNF652 in tumorigenesis.
    [Show full text]
  • 2017.08.28 Anne Barry-Reidy Thesis Final.Pdf
    REGULATION OF BOVINE β-DEFENSIN EXPRESSION THIS THESIS IS SUBMITTED TO THE UNIVERSITY OF DUBLIN FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 2017 ANNE BARRY-REIDY SCHOOL OF BIOCHEMISTRY & IMMUNOLOGY TRINITY COLLEGE DUBLIN SUPERVISORS: PROF. CLIONA O’FARRELLY & DR. KIERAN MEADE TABLE OF CONTENTS DECLARATION ................................................................................................................................. vii ACKNOWLEDGEMENTS ................................................................................................................... viii ABBREVIATIONS ................................................................................................................................ix LIST OF FIGURES............................................................................................................................. xiii LIST OF TABLES .............................................................................................................................. xvii ABSTRACT ........................................................................................................................................xix Chapter 1 Introduction ........................................................................................................ 1 1.1 Antimicrobial/Host-defence peptides ..................................................................... 1 1.2 Defensins................................................................................................................. 1 1.3 β-defensins .............................................................................................................
    [Show full text]
  • Examination of the Transcription Factors Acting in Bone Marrow
    THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) Examination of the transcription factors acting in bone marrow derived macrophages by Gergely Nagy Supervisor: Dr. Endre Barta UNIVERSITY OF DEBRECEN DOCTORAL SCHOOL OF MOLECULAR CELL AND IMMUNE BIOLOGY DEBRECEN, 2016 Table of contents Table of contents ........................................................................................................................ 2 1. Introduction ............................................................................................................................ 5 1.1. Transcriptional regulation ................................................................................................... 5 1.1.1. Transcriptional initiation .................................................................................................. 5 1.1.2. Co-regulators and histone modifications .......................................................................... 8 1.2. Promoter and enhancer sequences guiding transcription factors ...................................... 11 1.2.1. General transcription factors .......................................................................................... 11 1.2.2. The ETS superfamily ..................................................................................................... 17 1.2.3. The AP-1 and CREB proteins ........................................................................................ 20 1.2.4. Other promoter specific transcription factor families ...................................................
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Genetic Variability in the Italian Heavy Draught Horse from Pedigree Data and Genomic Information
    Supplementary material for manuscript: Genetic variability in the Italian Heavy Draught Horse from pedigree data and genomic information. Enrico Mancin†, Michela Ablondi†, Roberto Mantovani*, Giuseppe Pigozzi, Alberto Sabbioni and Cristina Sartori ** Correspondence: [email protected] † These two Authors equally contributed to the work Supplementary Figure S1. Mares and foal of Italian Heavy Draught Horse (IHDH; courtesy of Cinzia Stoppa) Supplementary Figure S2. Number of Equivalent Generations (EqGen; above) and pedigree completeness (PC; below) over years in Italian Heavy Draught Horse population. Supplementary Table S1. Descriptive statistics of homozygosity (observed: Ho_obs; expected: Ho_exp; total: Ho_tot) in 267 genotyped individuals of Italian Heavy Draught Horse based on the number of homozygous genotypes. Parameter Mean SD Min Max Ho_obs 35,630.3 500.7 34,291 38,013 Ho_exp 35,707.8 64.0 35,010 35,740 Ho_tot 50,674.5 93.8 49,638 50,714 1 Definitions of the methods for inbreeding are in the text. Supplementary Figure S3. Values of BIC obtained by analyzing values of K from 1 to 10, corresponding on the same amount of clusters defining the proportion of ancestry in the 267 genotyped individuals. Supplementary Table S2. Estimation of genomic effective population size (Ne) traced back to 18 generations ago (Gen. ago). The linkage disequilibrium estimation, adjusted for sampling bias was also included (LD_r2), as well as the relative standard deviation (SD(LD_r2)). Gen. ago Ne LD_r2 SD(LD_r2) 1 100 0.009 0.014 2 108 0.011 0.018 3 118 0.015 0.024 4 126 0.017 0.028 5 134 0.019 0.031 6 143 0.021 0.034 7 156 0.023 0.038 9 173 0.026 0.041 11 189 0.029 0.046 14 213 0.032 0.052 18 241 0.036 0.058 Supplementary Table S3.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • A Clinicopathological and Molecular Genetic Analysis of Low-Grade Glioma in Adults
    A CLINICOPATHOLOGICAL AND MOLECULAR GENETIC ANALYSIS OF LOW-GRADE GLIOMA IN ADULTS Presented by ANUSHREE SINGH MSc A thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of Philosophy Brain Tumour Research Centre Research Institute in Healthcare Sciences Faculty of Science and Engineering University of Wolverhampton November 2014 i DECLARATION This work or any part thereof has not previously been presented in any form to the University or to any other body whether for the purposes of assessment, publication or for any other purpose (unless otherwise indicated). Save for any express acknowledgments, references and/or bibliographies cited in the work, I confirm that the intellectual content of the work is the result of my own efforts and of no other person. The right of Anushree Singh to be identified as author of this work is asserted in accordance with ss.77 and 78 of the Copyright, Designs and Patents Act 1988. At this date copyright is owned by the author. Signature: Anushree Date: 30th November 2014 ii ABSTRACT The aim of the study was to identify molecular markers that can determine progression of low grade glioma. This was done using various approaches such as IDH1 and IDH2 mutation analysis, MGMT methylation analysis, copy number analysis using array comparative genomic hybridisation and identification of differentially expressed miRNAs using miRNA microarray analysis. IDH1 mutation was present at a frequency of 71% in low grade glioma and was identified as an independent marker for improved OS in a multivariate analysis, which confirms the previous findings in low grade glioma studies.
    [Show full text]
  • Farnesol-Induced Apoptosis in Human Lung Carcinoma Cells Is Coupled to the Endoplasmic Reticulum Stress Response
    Research Article Farnesol-Induced Apoptosis in Human Lung Carcinoma Cells Is Coupled to the Endoplasmic Reticulum Stress Response Joung Hyuck Joo,1 Grace Liao,1 Jennifer B. Collins,2 Sherry F. Grissom,2 and Anton M. Jetten1 1Cell Biology Section, LRB, and 2Microarray Group, Division of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina Abstract range of fruits and vegetables (9, 10). Each isoprenoid has been Farnesol (FOH) and other isoprenoid alcohols induce apopto- shown to inhibit proliferation and induce apoptosis in a number of sis in various carcinoma cells and inhibit tumorigenesis in neoplastic cell lines from different origins (4, 11–14). In addition, in vivo these isoprenoids have been reported to be effective in chemo- several models. However, the mechanisms by which in vivo they mediate their effects are not yet fully understood. In this prevention and chemotherapy in various cancer models study, we show that FOH is an effective inducer of apoptosis in (10, 12, 15, 16). FOH has been reported to exhibit chemopreventive several lung carcinoma cells, including H460. This induction is effects in colon and pancreas carcinogenesis in rats (9, 17) whereas associated with activation of several caspases and cleavage of phase I and II clinical trials have indicated therapeutic potential poly(ADP-ribose) polymerase (PARP). To obtain insight into for POH (16, 18). The mechanisms by which these isoprenoids induce these effects are not yet fully understood. Isoprenoids have the mechanism involved in FOH-induced apoptosis, we compared the gene expression profiles of FOH-treated and been reported to inhibit posttranslational protein prenylation (19) control H460 cells by microarray analysis.
    [Show full text]
  • Figure S1. Representative Report Generated by the Ion Torrent System Server for Each of the KCC71 Panel Analysis and Pcafusion Analysis
    Figure S1. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. A Figure S1. Continued. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. B Figure S2. Comparative analysis of the variant frequency found by the KCC71 panel and calculated from publicly available cBioPortal datasets. For each of the 71 genes in the KCC71 panel, the frequency of variants was calculated as the variant number found in the examined cases. Datasets marked with different colors and sample numbers of prostate cancer are presented in the upper right. *Significantly high in the present study. Figure S3. Seven subnetworks extracted from each of seven public prostate cancer gene networks in TCNG (Table SVI). Blue dots represent genes that include initial seed genes (parent nodes), and parent‑child and child‑grandchild genes in the network. Graphical representation of node‑to‑node associations and subnetwork structures that differed among and were unique to each of the seven subnetworks. TCNG, The Cancer Network Galaxy. Figure S4. REVIGO tree map showing the predicted biological processes of prostate cancer in the Japanese. Each rectangle represents a biological function in terms of a Gene Ontology (GO) term, with the size adjusted to represent the P‑value of the GO term in the underlying GO term database.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]